Laura Mercatali

Osteoncology and Rare Tumors Center, IRCCS

Affiliated withIRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Research Area

Cancer Research

Biography

Laura Mercatali has not added Biography.
If you are Laura Mercatali and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 3	Year
Publication title Cited by 6	2017
Publication title Cited by 16	2018
Publication title Cited by 9	2018

Other Publications

Article	Year
Ribosome-inactivating proteins depurinate poly(ADP-ribosyl)ated poly(ADP-ribose) polymerase and have transforming activity for 3T3 fibroblasts. FEBS letters\| PubMed ID: 12633875	2003
Cell-cycle deregulation in BALB/c 3T3 cells transformed by 1,2-dibromoethane and folpet pesticides. Environmental and molecular mutagenesis\| PubMed ID: 12802801	2003
Free DNA and carcinoembryonic antigen serum levels: an important combination for diagnosis of colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17145818	2006
Osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: a retrospective study. The oncologist\| PubMed ID: 18378544	2008
Multidisciplinary approach to the treatment of bone metastases: Osteo-Oncology Center, a new organizational model. Tumori\| PubMed ID: 19688966	2009
Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer\| PubMed ID: 20108337	2010
Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. The International journal of biological markers\| PubMed ID: 21161945	2010
Time-dependent pharmacokinetics of 5-fluorouracil and association with treatment tolerability in the adjuvant setting of colorectal cancer. Journal of clinical pharmacology\| PubMed ID: 21383342	2012
Bone metastases detection by circulating biomarkers: OPG and RANK-L. International journal of oncology\| PubMed ID: 21491082	2011
The role of CXCR4 in the prediction of bone metastases from breast cancer: a pilot study. Oncology\| PubMed ID: 21734413	2011
Role of RANK, RANKL, OPG, and CXCR4 tissue markers in predicting bone metastases in breast cancer patients. Clinical breast cancer\| PubMed ID: 21764390	2011
Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nature medicine\| PubMed ID: 21822286	2011
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2. Nature cell biology\| PubMed ID: 23086238	2012
Inhibition of breast cancer cell proliferation in repeated and non-repeated treatment with zoledronic acid. Cancer cell international\| PubMed ID: 23173568	2012
Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: clinical impact. Oncology\| PubMed ID: 23257904	2013
miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis. Nature cell biology\| PubMed ID: 23396050	2013
Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines. International journal of oncology\| PubMed ID: 23403907	2013
Multiple marker detection in peripheral blood for NSCLC diagnosis. PloS one\| PubMed ID: 23468981	2013
Metastatic bone disease in the era of bone-targeted therapy: clinical impact. Tumori\| PubMed ID: 23548992	2013
RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. International journal of molecular sciences\| PubMed ID: 23702841	2013
What can we learn from the ZOOM trial?--Authors' reply. The Lancet. Oncology\| PubMed ID: 23993381	2013
Bone and cancer: the osteoncology. Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases\| PubMed ID: 24133529	2013
Tumor-Induced Osteoclast miRNA Changes as Regulators and Biomarkers of Osteolytic Bone Metastasis. Cancer cell\| PubMed ID: 24135284	2013
A new emergency in oncology: Bone metastases in breast cancer patients (Review). Oncology letters\| PubMed ID: 24137321	2013
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems. Bone\| PubMed ID: 24956020	2014
The microRNA-23b/27b/24 cluster promotes breast cancer lung metastasis by targeting metastasis-suppressive gene prosaposin. The Journal of biological chemistry\| PubMed ID: 24966325	2014
ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling. Nature cell biology\| PubMed ID: 25241036	2014
Single bone metastasis from adenocarcinoma of the lacrimal gland: a case report. Future oncology (London, England)\| PubMed ID: 25303054	2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literature. OncoTargets and therapy\| PubMed ID: 25364262	2014
Pleural effusion in a patient with metastatic gastrointestinal stromal tumor treated with imatinib: case report. Future oncology (London, England)\| PubMed ID: 25525851	2014
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. OncoTargets and therapy\| PubMed ID: 26664145	2015
Long-lasting activity of trabectedin in refractory uterine leiomyosarcoma: a case report. BMC cancer\| PubMed ID: 26695071	2015
Development of a Patient-Derived Xenograft (PDX) of Breast Cancer Bone Metastasis in a Zebrafish Model. International journal of molecular sciences\| PubMed ID: 27556456	2016
Recombinant granulocyte colony-stimulating factor (rG-CSF) in the management of neutropenia induced by anthracyclines and ifosfamide in patients with soft tissue sarcomas (NEUSAR). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 27568305	2017
[Corrigendum] Cisplatin in combination with zoledronic acid: A synergistic effect in triple-negative breast cancer cell lines. International journal of oncology\| PubMed ID: 27573164	2016
RANKL: A promising circulating marker for bone metastasis response. Oncology letters\| PubMed ID: 27698885	2016
Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas. OncoTargets and therapy\| PubMed ID: 27785071	2016
The Effect of Everolimus in an In Vitro Model of Triple Negative Breast Cancer and Osteoclasts. International journal of molecular sciences\| PubMed ID: 27809291	2016
Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biology open\| PubMed ID: 27895047	2017
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer. Oncotarget\| PubMed ID: 27911856	2017
Activity of Eribulin in a Primary Culture of Well-Differentiated/Dedifferentiated Adipocytic Sarcoma. Molecules (Basel, Switzerland)\| PubMed ID: 27918490	2016
Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of (18)FDG-PET/CT. Clinical lung cancer\| PubMed ID: 27956089	2017
Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway. Oncotarget\| PubMed ID: 28061456	2017
CORRECTION: Innovative approaches to establish and characterize primary cultures: an ex vivo 3D system and the zebrafish model. Biology open\| PubMed ID: 28202474	2017
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas. OncoTargets and therapy\| PubMed ID: 28260930	2017
Tumor-Stroma Crosstalk in Bone Tissue: The Osteoclastogenic Potential of a Breast Cancer Cell Line in a Co-Culture System and the Role of EGFR Inhibition. International journal of molecular sciences\| PubMed ID: 28758931	2017
Management and potentialities of primary cancer cultures in preclinical and translational studies. Journal of translational medicine\| PubMed ID: 29116016	2017
Primary leiomyosarcoma of the bone: a case report and a review of the literature. Medicine\| PubMed ID: 29137065	2017
Osteoblastic bone metastases from neuroendocrine tumor (NET) of unknown origin detected by 18fluorocholine PET/CT and its comparison with 68gallium-DOTATOC PET/CT: Case report and review of ... Medicine\| PubMed ID: 29145267	2017
Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents. International journal of molecular sciences\| PubMed ID: 29292724	2017
Myxofibrosarcoma primary cultures: molecular and pharmacological profile. Therapeutic advances in medical oncology\| PubMed ID: 29449896	2017